<DOC>
	<DOCNO>NCT00569101</DOCNO>
	<brief_summary>The purpose protocol determine whether Tacrolimus Prednisolone effective safe treatment cyclophosphamide-resistant , refractory diffuse proliferative lupus nephritis</brief_summary>
	<brief_title>A Pilot Study Efficacy Safety Tacrolimus Treatment Refractory Lupus Nephritis</brief_title>
	<detailed_description />
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Lupus Nephritis</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Biopsyproven lupus nephritis WHO Class IV , IV+V Previously treat three time i.v . cyclophosphamide 6 month duration immunosuppressive treatment ( azathioprine , MMF , cyclophosphamide p.o . ) lupus nephritis spot urine Protein creatinine raio &gt; 1.0 RBC &gt; 5 /HPF microscopic examination urine previous treatment cyclosporine A tacrolimus serum Creatinine lever : 300 mmol/dl allergy macrolide antibiotic systemic organ damage</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>